The HIV+Hepatitis Policy Institute is a national nonprofit advocacy organization focused on improving access to quality, affordable healthcare for people living with or at risk of HIV, viral hepatitis, and other serious chronic health conditions.
Health care access, HIV prevention and treatment, viral hepatitis prevention and treatment, federal public health funding, insurance coverage, patient access to medications and preventive services, and related health policy advocacy.
Primarily supported by individuals, foundations, and corporate sponsors/donors.
Led by Executive Director Carl Schmid; board and policy relationships include leaders from Gilead Sciences, ViiV Healthcare, the American Cancer Society Cancer Action Network, Positive Impact Health Centers, and former federal HIV/AIDS officials.
Non-profit organization (501(c)(3))